A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Sulfonylurea in Type 2 Diabetic Patients

NCT01242215 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

243

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DEVICE: ipragliflozin
DRUG: Placebo
DRUG: Sulfonylurea

Sponsor

Astellas Pharma Inc